NO20014770L - Association of NO synthase inhibitor (s) and metabolic antioxidants - Google Patents

Association of NO synthase inhibitor (s) and metabolic antioxidants

Info

Publication number: NO20014770L
Authority: NO; Norway
Prior art keywords: association; synthase inhibitor; metabolic; antioxidants; metabolic antioxidants
Prior art date: 1999-04-02

Application number

NO20014770A

Other languages

Norwegian (no)

Other versions

NO20014770D0 (en

Inventor

Michel Auguet

Jeremiah Harnett

Pierre-Etienne Cha Lassauniere

Original Assignee

Sod Conseils Rech Applic

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-04-02

Filing date

2001-10-01

Publication date

2001-11-23

2001-10-01 Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic

2001-10-01 Publication of NO20014770D0 publication Critical patent/NO20014770D0/en

2001-11-23 Publication of NO20014770L publication Critical patent/NO20014770L/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Diabetes (AREA)
Psychiatry (AREA)
Hematology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Addiction (AREA)
Pain & Pain Management (AREA)
Immunology (AREA)
Urology & Nephrology (AREA)
Rheumatology (AREA)
Dermatology (AREA)
Endocrinology (AREA)
Obesity (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Tropical Medicine & Parasitology (AREA)
Toxicology (AREA)
Communicable Diseases (AREA)
Ophthalmology & Optometry (AREA)
Oncology (AREA)
Virology (AREA)
Vascular Medicine (AREA)

NO20014770A 1999-04-02 2001-10-01 Association of NO synthase inhibitor (s) and metabolic antioxidants NO20014770L (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR9904134A FR2791571B1 (en)	1999-04-02	1999-04-02	ASSOCIATION OF NO SYNTHASE INHIBITOR (S) AND METABOLIC ANTIOXIDANT (S)
PCT/FR2000/000812 WO2000059448A2 (en)	1999-04-02	2000-03-31	Association of no-synthase inhibitor(s) and metabolic antioxidant(s)

Publications (2)

Publication Number	Publication Date
NO20014770D0 NO20014770D0 (en)	2001-10-01
NO20014770L true NO20014770L (en)	2001-11-23

Family

ID=9543945

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20014770A NO20014770L (en)	1999-04-02	2001-10-01	Association of NO synthase inhibitor (s) and metabolic antioxidants

Country Status (9)

Country	Link
EP (1)	EP1169005A2 (en)
JP (1)	JP2002541077A (en)
AR (1)	AR023219A1 (en)
AU (1)	AU3663700A (en)
CA (1)	CA2365500A1 (en)
FR (1)	FR2791571B1 (en)
MY (1)	MY133230A (en)
NO (1)	NO20014770L (en)
WO (1)	WO2000059448A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2816509B1 (en) *	2000-11-15	2004-02-06	Sod Conseils Rech Applic	ASSOCIATION OF CALPAIN INHIBITORS AND OXYGEN REACTIVE TRAPS
US6476073B1 (en) *	2000-11-21	2002-11-05	Arthur Vanmoor	Method of treating a hangover by enhancing the effectiveness of the human immune system
CA2515929C (en) *	2003-02-14	2013-11-19	Children's Hospital & Research Center At Oakland	Treatment of conditions associated with decreased nitric oxide bioavailability, including elevated arginase conditions
DE602005012089D1 (en)	2005-08-04	2009-02-12	Extarma Ag	Liquid composition containing arginine and alpha-lipoic acid to improve sexual function
WO2009111037A2 (en) *	2008-03-04	2009-09-11	Indigene Pharmaceuticals Inc.	Compositions and methods for treating nos-associated diseases
US20110104308A1 (en) *	2008-05-09	2011-05-05	Duke University	Treatment For Diseases Relying On Discovery That Thioredoxin Mediates Nitric Oxide
TWI592156B (en) *	2011-10-04	2017-07-21	艾可達醫療公司	Method for treating sensory motion damage associated with stroke using aminopyridine
JPWO2013129642A1 (en) *	2012-03-02	2015-07-30	協和発酵バイオ株式会社	Eating and / or gastrointestinal activity promoter
AU2013286876B2 (en) *	2012-07-03	2017-04-20	Jay Pravda	Methods for treating, diagnosing and/or monitoring progression of oxo associated states

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR4630M (en) *	1965-06-09	1966-11-28
ZA716628B (en) *	1970-10-15	1972-06-28	Richardson Merrell Spa	Composition and method for treatment of hepatic disease and mental fatigue
US5091180A (en) *	1987-11-20	1992-02-25	Administrators Of The Tulane Educational Fund	Protection against rhabdomyolysis-induced nephrotoxicity
US5455279A (en) *	1991-04-19	1995-10-03	The Children's Medical Center Corporation	Regimen method of mediating neuronal damage using nitroglycerine
US5852058A (en) *	1993-06-11	1998-12-22	The Board Of Trustees Of The Leland Stanford Junior University	Intramural delivery of nitric oxide enhancer for inhibiting lesion formation after vascular injury
GB9404400D0 (en) *	1994-03-07	1994-04-20	Wood Pauline J	Potentiation of bioreductive agents
DE4420102A1 (en) *	1994-06-09	1995-12-14	Asta Medica Ag	Combination prepns. contg. alpha-liponic acid or its metabolites
AU5317296A (en) *	1995-03-24	1996-10-16	Francis V. Defeudis	Methods for treating conditions associated with excess nitri c oxide
US5951990A (en) *	1995-05-15	1999-09-14	Avon Products, Inc.	Ascorbyl-phosphoryl-cholesterol
EP0891719A1 (en) *	1997-07-14	1999-01-20	N.V. Nutricia	Nutritional composition containing methionine
AU8768098A (en) *	1997-08-04	1999-02-22	Christopher J. Berry	Method of treating disease using a tocotrienol and alpha-lipoic acid r derivatives or an ester thereof
AU759467B2 (en) *	1998-04-02	2003-04-17	Avicena Group, Inc.	Compositions containing a combination of a creatine compound and a second agent

1999
- 1999-04-02 FR FR9904134A patent/FR2791571B1/en not_active Expired - Lifetime
2000
- 2000-03-29 MY MYPI20001265A patent/MY133230A/en unknown
- 2000-03-30 AR ARP000101440A patent/AR023219A1/en unknown
- 2000-03-31 EP EP00915262A patent/EP1169005A2/en not_active Withdrawn
- 2000-03-31 WO PCT/FR2000/000812 patent/WO2000059448A2/en active Search and Examination
- 2000-03-31 JP JP2000609013A patent/JP2002541077A/en active Pending
- 2000-03-31 AU AU36637/00A patent/AU3663700A/en not_active Abandoned
- 2000-03-31 CA CA002365500A patent/CA2365500A1/en not_active Abandoned
2001
- 2001-10-01 NO NO20014770A patent/NO20014770L/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
CA2365500A1 (en)	2000-10-12
NO20014770D0 (en)	2001-10-01
AU3663700A (en)	2000-10-23
MY133230A (en)	2007-10-31
FR2791571A1 (en)	2000-10-06
JP2002541077A (en)	2002-12-03
WO2000059448A3 (en)	2001-03-08
FR2791571B1 (en)	2002-10-04
EP1169005A2 (en)	2002-01-09
AR023219A1 (en)	2002-09-04
WO2000059448A2 (en)	2000-10-12

Publication	Publication Date	Title
NO20032668L (en)	2003-06-12	Gyrase Inhibitors and Uses thereof
EP1383743A4 (en)	2006-04-12	Dual inhibitors of pde 7 and pde 4
NO20014823L (en)	2001-10-04	Heterocycle-containing biphenyl-αP2 inhibitors and method
HK1053984B (en)	2006-07-28	Gyrase inhibitors and uses thereof
IS6385A (en)	2002-05-15	New uses and new N-azabicyclo-amide derivatives
IL149118A0 (en)	2002-11-10	Inhibitors of neuraminidases
PL375877A1 (en)	2005-12-12	Hydantoine derivatives and their use as tace inhibitors
NO20030725D0 (en)	2003-02-14	Therapeutic combination of CETP inhibitor and atorvastatin
EP1474445A4 (en)	2007-02-21	Glycoisoforms of adiponectin and uses thereof
IS6934A (en)	2003-08-29	New spirotycyclic derivatives and their use as phosphodiesterase-7 inhibitors
HUP0304052A3 (en)	2010-06-28	Heterocyclic inhibitors of erk2 and uses thereof
NO20013393D0 (en)	2001-07-09	Well cementing methods and compositions
AU2003303128A8 (en)	2004-08-13	Inhibitors and methods of use thereof
IL152078A0 (en)	2003-05-29	8-quinolinxanthine and 8-isoquinolinxanthine derivatives as pde 5 inhibitors
NO20015274D0 (en)	2001-10-29	ACE-2 inhibitory compounds and methods of use thereof
NO20032441D0 (en)	2003-05-28	Combination of GABA agonists and sorbitol dehydrogenase inhibitors
AU2003239544A1 (en)	2003-12-12	Amplification and overexpression of oncogenes
NO20014770L (en)	2001-11-23	Association of NO synthase inhibitor (s) and metabolic antioxidants
AU2003210983A8 (en)	2003-09-04	Kinase inhibitors and methods of use thereof
IL131047A0 (en)	2001-01-28	Use of il-18 inhibitors
NO20020326L (en)	2002-03-20	Composition and use of an inhibitor of PPAR delta activity
EP1304038A4 (en)	2008-10-08	METABOLIC INHIBITORS AGAINST BRASSINOSTEROIDS
AU2003254064A8 (en)	2004-02-25	Amplification and overexpression of oncogenes
AU2003285686A8 (en)	2004-07-14	Glycoisoforms of adiponectin and uses thereof
DK1228026T3 (en)	2004-04-05	15-Hydroxyicosatetraenoic acid related compounds and methods of use

Legal Events

Date	Code	Title	Description
2006-10-30	FC2A	Withdrawal, rejection or dismissal of laid open patent application